FABHALTA Now FDA-Approved for PNH

  Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired hematopoietic stem cell disorder in which blood cells break apart prematurely. In an effort to bring more effective and targeted treatments…

Continue Reading FABHALTA Now FDA-Approved for PNH